ETNB Overview
Upcoming Projects (ETNB)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ETNB)
-
Exploring the current treatment landscape and the future direction of available NASH specific drugs with the introduction of GLP-1 agonists
Tickers: MDGL, TERN, ETNB, VKTX
Executed On: Sep 19, 2023 at 10:00 AM EDT -
A Second Look: Comparing 89bio's pegozafermin to Akero's efruxifermin in NASH
Tickers: ETNB, AKRO
Executed On: Mar 28, 2023 at 11:00 AM EDT -
Comparing 89bio's ENLIVEN data (pegozafermin) to Akero's efruxifermin in NASH
Tickers: ETNB, AKRO, MDGL, ICPT
Executed On: Mar 23, 2023 at 02:30 PM EDT -
A Second View: Discussing 89bio’s pegozafermin in severe hypertriglyceridemia, following Phase 2 Data Results
Ticker: ETNB
Executed On: Oct 21, 2022 at 12:00 PM EDT -
Discussing 89bio’s pegozafermin in severe hypertriglyceridemia, following Phase 2 Data Results
Ticker: ETNB
Executed On: Oct 12, 2022 at 01:30 PM EDT
Upcoming & Overdue Catalysts (ETNB)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (ETNB)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
